LGR6 promotes glioblastoma malignancy and chemoresistance by activating the Akt signaling pathwayYuan Cheng(Taian City Central Hospital), Fang Xie(Guangxi Buffalo Research Institute)Experimental and Therapeutic MedicineSeptember 27, 202110.3892/etm.2021.10798Cited by 11SaveCiteExport RISWatch citationsRelated PapersOdronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study|Blood|2024|28Long-Term Efficacy and Safety of Odronextamab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Pooled Analysis from the ELM-1 and ELM-2 Studies|Blood|2024|6